The Cooper Companies Inc. (COO)
NASDAQ: COOHealth CareOphthalmic GoodsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
COO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $11.20B
- P/E (TTM)
- 20.23
- Forward P/E
- 12.55
- EPS (TTM)
- $2.91
- Dividend yield
- None
- Ex-dividend date
- Jul 26, 2023
- 52-week range
- 51.01 – 89.83
- Day range
- 58.66 – 60.98
- Volume / Avg
- 2.08M / 3.55M
- Beta
- —
- Shares outstanding
- 190.16M
- Next earnings
- Dec 3, 2026
52-week range
COO stock today
On Nov 20, COO ended the session at $58.88, shedding $1.45 (2.40%), versus the S&P 500's 3.70% decline. Shares are 34.5% below their 52-week high of $89.83, set on Dec 5, 2025 and 15.4% above the 52-week low of $51.01, in the middle of the past year's range. COO is down 28.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 22.0%.
At 20.2x trailing earnings, Cooper Companies trades below the peer-group median of 37.3x. Its forward P/E of 12.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. The company is scheduled to report Oct/2026 results on Dec 3 after the market closes; analysts expect EPS of $1.07.
Summary generated from market data by MetaCap's automated system. Methodology
About Cooper Companies
Company profileThe Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- CEO
- Mr. Albert G. White III
- Headquarters
- San Ramon, CA
- Employees
- 15,000
- Website
- coopercos.com
Financial highlights
Full financialsIn fiscal 2025, Cooper Companies generated $4.09 billion in revenue, up 5.1% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $374.9 million (-4.4% year over year), for a net margin of 9.2% versus a median of 10.1% in the prior 5 years. Gross margin was 65.5% (down from 66.6%) and operating margin 16.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Growth | +5.06% | +8.41% | +8.61% | +13.20% | +20.22% |
| Net income | $374.90M | $392.30M | $294.20M | $385.80M | $2.94B |
| EPS (diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 |
Analyst forecast
ForecastConsensus (17 analysts)
hold
Avg. price target
$65.80+11.75%
- Strong buy 2
- Buy 3
- Hold 12
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Dec 3, 2026
- EPS estimate
- $1.07
- Last reported (Q3 2026)
- Sep 9, 2026
- EPS actual vs est.
- $2.24 vs —
Dividends
Dividend history- Annual dividend
- $0.00
- Last payment
- $0.0075
- Ex-dividend date
- Jul 26, 2023
COO news
All COO news- MARKER THERAPEUTICS, INC. (MRKR) Reports Q3 Loss, Lags Revenue EstimatesNasdaqMRKR, COO
- Twist Bioscience (TWST) Reports Q4 Loss, Beats Revenue EstimatesNasdaqTWST, COO
- Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COOPR Newswire
- Lifevantage (LFVN) Surpasses Q1 Earnings EstimatesNasdaqLFVN, COO
- Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COOPR Newswire
- CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2026GlobeNewswire
- Cardinal Health (CAH) Q1 Earnings and Revenues Top EstimatesNasdaqCAH, COO
- Rosen Law Firm Encourages The Cooper Companies, Inc. Investors to Inquire About Securities Class Action Investigation - COOPR Newswire
Cooper Companies peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| BLCOBausch + Lomb Corporation | 19.38 | -6.33% | $6.93B | vs COO |
| WRBYWarby Parker Inc. Class A | 23.12 | -4.19% | $2.87B | vs COO |
| EYENational Vision Holdings Inc. | 16.72 | -1.70% | $1.31B | vs COO |
| STAASTAAR Surgical Company | 24.22 | -3.24% | $1.22B | vs COO |
| RXSTRxSight Inc. | 4.47 | -3.04% | $187.42M | vs COO |
| LUCYInnovative Eyewear Inc. | 0.7025 | -0.07% | $6.12M | vs COO |
| ALCAlcon Inc. | 74.31 | -0.26% | $35.70B | vs COO |
Indexes, lists and sector
Cooper Companies stock FAQ
What is Cooper Companies's stock price today?
COO last traded at $58.88 as of Nov 20, 4:00 PM EST, down 2.40% on the day. Prices are delayed at least 15 minutes.
Does Cooper Companies pay a dividend?
Yes. Cooper Companies pays $0.00 per share annually. The most recent dividend of $0.0075 had an ex-dividend date of Jul 26, 2023.
When is Cooper Companies's next earnings date?
Cooper Companies is expected to report earnings on Thursday, December 3, 2026. Analysts expect EPS of $1.07.
What is COO's P/E ratio?
COO trades at a trailing P/E ratio of 20.23 and a forward P/E of 12.55, compared with a median of 37.3 for its closest peers.
Is Cooper Companies in the S&P 500?
Yes. Cooper Companies (COO) is a constituent of the S&P 500 index.
Who is Cooper Companies's CEO?
Mr. Albert G. White III is the chief executive officer of The Cooper Companies Inc., which has about 15,000 employees.
Has COO ever split its stock?
Yes. The most recent COO stock split was a 4-for-1 split on Feb 20, 2024, one of 3 splits on record.